John Abraham: Understanding rFVIIa Through the Cell Based Model of Coagulation
John Abraham, Assistant Professor at Christian Medical College and Hospital, shared a post on LinkedIn:
“Recently co-authored a chapter on clotting disorders in pregnancy.
While writing it, I went back and deep dived into the cell-based model of coagulation — and somewhere along the way, something just clicked.
Revisiting the model :
- Initiation gives only a small thrombin signal
- Amplification prepares the platelet surface
- Propagation is where the real action happens – thrombin burst
The system is designed so that effective clotting is platelet-surface driven
The moment of clarity: rFVIIa (NovoSeven)
While going through this, the mechanism suddenly made complete sense:
- If clot formation depends on platelet-surface thrombin generation
- Then you don’t necessarily need the entire intrinsic pathway
rFVIIa at pharmacologic doses:
- Acts directly on activated platelets
- Generates FXa independent of TF
- Bypasses FVIII / FIX
Result: restoration of the thrombin burst exactly where it matters
Why this felt important:
- Explains its efficacy in hemophilia with inhibitors
- Connects physiology – pharmacology in a very direct way
- Turns what feels like a ‘black box drug’ into a predictable mechanism
A good reminder — sometimes revisiting what you already know, but in depth, can change how clearly you see it.”

Stay updated with Hemostasis Today.
-
Nov 18, 2026, 15:11Vansh Yaduvanshi: Why Compatible Blood Groups Do Not Always Mean Compatible Blood
-
Nov 18, 2026, 14:49Estetrol-Based Contraception in PCOS and Its Effects on Coagulation – RPTH Journal
-
Nov 18, 2026, 14:41Factor V Deficiency: Diagnostic Challenges and the Role of Combined Factor V and VIII Deficiency
-
Nov 18, 2026, 14:29Maxime Dely: When Patient Encounters Become Life Lessons
-
Nov 18, 2026, 14:23Basanta Khatiwada: Advancing Haematology Through Research and Innovation at HAEMATOCON 2026
-
Nov 18, 2026, 14:13Alvin Katumba: Sickle Cell Disease Research Recognised With a 2026 ASH Abstract Achievement Award
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: The Ecological Transition in Thrombosis and Haemostasis